rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Brett Hale

CFO and CAO

Company insider

Files Form 4 as: CFO and CAO, Hyperfine.

In numbers

Trades disclosed
11
Buys
0
Sells
3
Bought
$0
Sold
$91K
Companies
1
Companies where not an officer
0
First trade
13 Feb 2023
Last trade
24 Aug 2026
Last filed
25 Aug 2026

Companies traded

Where they are an officer
HYPR HyperfineOfficer · Medical Devices · last 24 Aug 20260 buys · 3 sells

Activity over time

1 Mar – 1 Oct
10Mar 26May 26Jul 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
24 Aug 2026filed 25 Aug 2026HYPR HyperfineMedical DevicesSEC FORM 4 Sold$6,2737,345 at $0.854filing
24 Aug 2026filed 25 Aug 2026HYPR HyperfineMedical DevicesSEC FORM 4 Sold$6,2437,345 at $0.85filing
26 May 2026filed 27 May 2026HYPR HyperfineMedical DevicesSEC FORM 4 Sold$9,9786,047 at $1.65filing
26 May 2026filed 27 May 2026HYPR HyperfineMedical DevicesSEC FORM 4 Sold$9,9786,047 at $1.65filing
31 Mar 2026filed 1 Apr 2026HYPR HyperfineMedical DevicesSEC FORM 4 Code A—330,000 at $0.00filing
31 Mar 2026filed 1 Apr 2026HYPR HyperfineMedical DevicesSEC FORM 4 Code A—330,000 at $0.00filing
23 Mar 2026filed 25 Mar 2026HYPR HyperfineMedical DevicesSEC FORM 4 Sold$29K24,188 at $1.21filing
23 Mar 2026filed 25 Mar 2026HYPR HyperfineMedical DevicesSEC FORM 4 Sold$29K24,188 at $1.21filing
31 Mar 2025filed 20 May 2025HYPR HyperfineMedical DevicesSEC FORM 4 Code A—300,000 at $0.00filing
28 Mar 2024filed 28 Mar 2024HYPR Hyperfineoption or derivative · Medical DevicesSEC FORM 4 Code A—500,000 at $0.00filing
13 Feb 2023filed 15 Feb 2023HYPR Hyperfineoption or derivative · Medical DevicesSEC FORM 4 Code A—1,000,000 at $0.00filing

News

Critical Review: Beta Bionics (NASDAQ:BBNX) vs. Hyperfine (NASDAQ:HYPR)HYPR · dailypolitical.com · 14 Oct 2026

0 headlines in the last 90 days name Brett Hale; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Thomas TeisseyreChief Operating Officer · Chief Operating Officer at Hyperfine, filing Form 4 there in the last year
Dan WoltermanDirector · Director at Hyperfine, filing Form 4 there in the last year
Jonathan M. RothbergDirector · Director and 10% owner at Hyperfine, filing Form 4 there in the last year
Ruth A. FattoriDirector · Director at Hyperfine, filing Form 4 there in the last year
John T. DahldorfDirector · Director at Hyperfine, filing Form 4 there in the last year